Study of the Mupirocin effect on Nasal Staph aureus decolonization and prevention of Intensive Care Unit infection: A Clinical Trial
Phase 2
- Conditions
- osocomial Infection with staphylococcus aureus.Staphylococcal infection, unspecified siteA49.0-
- Registration Number
- IRCT2013110915327N1
- Lead Sponsor
- Vice Chancellor for research of Arak University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 170
Inclusion Criteria
Patients admitted to Intensive Care Unit ; Age 16 years and more.
Exclusion criteria: incomplete treatment period
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method asal carrierity. Timepoint: 48 hours after admission. Method of measurement: Positive Culture.;Staphylococcus aureus infection. Timepoint: During the time of hospitalization and 10 days after discharge. Method of measurement: Positive Culture.
- Secondary Outcome Measures
Name Time Method